Induction	O
of	O
NF-kappa	B-protein
B	I-protein
during	O
monocyte	O
differentiation	O
is	O
associated	O
with	O
activation	O
of	O
HIV-gene	O
expression	O
.	O

Cells	O
of	O
the	O
monocyte-macrophage	B-cell_type
lineage	I-cell_type
are	O
important	O
targets	O
of	O
HIV	O
infection	O
.	O

We	O
report	O
here	O
that	O
the	O
phenotypic	O
differentiation	O
of	O
monocyte	B-cell_line
cell	I-cell_line
lines	I-cell_line
induced	O
by	O
phorbol	O
esters	O
or	O
tumour	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF	B-protein
alpha	I-protein
)	O
is	O
associated	O
with	O
expression	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
.	O

In	O
parallel	O
with	O
such	O
differentiation	O
,	O
HIV	O
transcription	O
,	O
monitored	O
using	O
an	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
reporter	I-DNA
gene	I-DNA
construct	I-DNA
,	O
is	O
activated	O
in	O
such	O
cells	O
under	O
the	O
influence	O
of	O
enhanced	O
NF-kappa	B-protein
B	I-protein
expression	O
.	O

Also	O
,	O
in	O
a	O
promonocyte	B-cell_line
cell	I-cell_line
line	I-cell_line
chronically	O
infected	O
with	O
HIV	O
,	O
NF-kappa	B-protein
B	I-protein
expression	O
and	O
HIV	O
transcription	O
were	O
enhanced	O
on	O
stimulation	O
with	O
phorbol	O
ester	O
or	O
TNF	B-protein
alpha	I-protein
.	O

Thus	O
,	O
stimulation	O
of	O
monocyte	B-cell_line
cell	I-cell_line
lines	I-cell_line
by	O
phorbol	O
esters	O
or	O
TNF	B-protein
alpha	I-protein
induces	O
cell	O
differentiation	O
and	O
activates	O
HIV	O
transcription	O
.	O

Such	O
a	O
process	O
may	O
have	O
fundamental	O
implications	O
in	O
AIDS	O
pathogenesis	O
in	O
vivo	O
and	O
may	O
be	O
important	O
in	O
disease	O
progression	O
induced	O
by	O
opportunistic	O
infections	O
directly	O
or	O
indirectly	O
involving	O
macrophages	B-cell_type
.	O

©	NULL
Institut	NULL
Pasteur/EcsEviegr	NULL
Paris	NULL
1991	NULL
Res	NULL
.	NULL

Virol	NULL
.	NULL

1991	NULL
,	NULL
142	NULL
,	NULL
233-238	NULL
Induction	NULL
of	NULL
NF-xB	NULL
during	NULL
monocyte	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
HIV-gene	NULL
expression	NULL
G.E	NULL
.	NULL

Griffin	NULL
(	NULL
,	NULL
K.	NULL
Leung	NULL
@	NULL
,	NULL
T.M	NULL
.	NULL

Folks	NULL
©	NULL
,	NULL
S.	NULL
Kunkel	NULL
and	NULL
G.J	NULL
.	NULL

Nabel	NULL
@	NULL
©	NULL
Division	NULL
of	NULL
Communicable	NULL
Diseases	NULL
,	NULL
St.	NULL
George	NULL
's	NULL
Hospital	NULL
Medical	NULL
School	NULL
,	NULL
Tooting	NULL
,	NULL
London	NULL
,	NULL
SW17	NULL
ORE	NULL
,	NULL
&	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Centre	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109	NULL
(	NULL
USA	NULL
)	NULL
,	NULL
©	NULL
Retrovirus	NULL
Diseases	NULL
Branch	NULL
,	NULL
CDC	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
30333	NULL
(	NULL
USA	NULL
)	NULL
,	NULL
and	NULL
@	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
School	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109	NULL
(	NULL
USA	NULL
)	NULL
SUMMARY	NULL
Cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
are	NULL
important	NULL
targets	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
phenotypic	NULL
differentiation	NULL
of	NULL
monocyte	NULL
cell	NULL
lines	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
or	NULL
tumour	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF	NULL
«	NULL
)	NULL
is	NULL
associated	NULL
with	NULL
expression	NULL
of	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
(	NULL
NF-xB	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
with	NULL
such	NULL
differentiation	NULL
,	NULL
HIV	NULL
transcription	NULL
,	NULL
monitored	NULL
using	NULL
an	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
reporter	NULL
gene	NULL
construct	NULL
,	NULL
is	NULL
activated	NULL
in	NULL
such	NULL
cells	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
enhanced	NULL
NF-xB	NULL
expression	NULL
.	NULL

Also	NULL
.	NULL

in	NULL
a	NULL
promanucyte	NULL
cell	NULL
lise	NULL
shroni-cally	NULL
infected	NULL
with	NULL
HIV	NULL
,	NULL
NF-xB	NULL
expressions	NULL
and	NULL
HMIY	NULL
transcription	NULL
were	NULL
enhanced	NULL
on	NULL
stimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
or	NULL
TNF	NULL
«	NULL
.	NULL

Thus	NULL
,	NULL
stimulation	NULL
of	NULL
monocyte	NULL
cell	NULL
lines	NULL
by	NULL
phor-bot	NULL
esters	NULL
or	NULL
TNF	NULL
«	NULL
induces	NULL
cell	NULL
differentiation	NULL
and	NULL
activates	NULL
HIV	NULL
transcription	NULL
.	NULL

Such	NULL
a	NULL
process	NULL
may	NULL
have	NULL
fundamental	NULL
implications	NULL
in	NULL
AIDS	NULL
pathogenesis	NULL
in	NULL
vivo	NULL
and	NULL
may	NULL
be	NULL
important	NULL
in	NULL
disease	NULL
progression	NULL
induced	NULL
by	NULL
opportunistic	NULL
infections	NULL
directly	NULL
or	NULL
indirectly	NULL
involving	NULL
macrophages	NULL
.	NULL

Key-words	NULL
:	NULL
HIV	NULL
,	NULL
Monocyte	NULL
,	NULL
Macrophage	NULL
,	NULL
AIDS	NULL
,	NULL
NF-xB	NULL
;	NULL
Phorbol	NULL
ester	NULL
,	NULL
TNFa	NULL
,	NULL
Cell	NULL
maturation	NULL
,	NULL
Transcription	NULL
.	NULL

INTRODUCTION	NULL
Monocytes	NULL
provide	NULL
an	NULL
important	NULL
cellular	NULL
reservoir	NULL
for	NULL
HIV	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Meltzer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
monocyte	NULL
macrophages	NULL
throughout	NULL
the	NULL
body	NULL
into	NULL
both	NULL
organs	NULL
of	NULL
the	NULL
reticulo-endothelial	NULL
system	NULL
,	NULL
e.g	NULL
.	NULL

lymph	NULL
nodes	NULL
and	NULL
spleen	NULL
and	NULL
virtually	NULL
all	NULL
other	NULL
organ	NULL
systems	NULL
,	NULL
may	NULL
provide	NULL
an	NULL
important	NULL
vector	NULL
for	NULL
the	NULL
virus	NULL
thus	NULL
facilitating	NULL
its	NULL
widespread	NULL
dis	NULL
semination	NULL
.	NULL

Macrophages	NULL
are	NULL
derived	NULL
from	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
under	NULL
appropriate	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
e.g	NULL
.	NULL

granulocyte-macrophage/colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
it	NULL
is	NULL
thought	NULL
that	NULL
such	NULL
marrow	NULL
stem	NULL
cells	NULL
may	NULL
be	NULL
chronically	NULL
infected	NULL
per	NULL
se	NULL
(	NULL
Donahue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Folks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
monocytes	NULL
and	NULL
macrophages	NULL
may	NULL
become	NULL
infected	NULL
directly	NULL
by	NULL
CD4-receptor-mediated	NULL
mechan-isms	NULL
.	NULL

Terminal	NULL
differentiation	NULL
into	NULL
the	NULL
macrophage	NULL
phenotype	NULL
may	NULL
be	NULL
induced	NULL
artificially	NULL
in	NULL
vitro	NULL
using	NULL
phorbol	NULL
esters	NULL
or	NULL
by	NULL
more	NULL
physiological	NULL
stimuli	NULL
such	NULL
as	NULL
tumour	NULL
necrosis	NULL
factor	NULL
(	NULL
TNFa	NULL
)	NULL
.	NULL

We	NULL
report	NULL
,	NULL
in	NULL
this	NULL
paper	NULL
,	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
in	NULL
which	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
in	NULL
this	NULL
differentiation	NULL
process	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
this	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
HIV	NULL
transcription	NULL
in	NULL
such	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

234	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
cells	NULL
were	NULL
maintained	NULL
'	NULL
n	NULL
RPMI	NULL
medium	NULL
enriched	NULL
with	NULL
7.5	NULL
%	NULL
foetal	NULL
calf	NULL
serum	NULL
,	NULL
glutamine	NULL
and	NULL
supplemented	NULL
with	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

Cell	NULL
lines	NULL
of	NULL
promonocytic	NULL
phenotype	NULL
HL60	NULL
and	NULL
U937	NULL
(	NULL
non-adherent	NULL
,	NULL
absent	NULL
Mol	NULL
expression	NULL
,	NULL
non-phagocytic	NULL
,	NULL
non-specific-esterase-negative	NULL
)	NULL
were	NULL
of	NULL
human	NULL
origin	NULL
.	NULL

Cells	NULL
of	NULL
mature	NULL
macrophage	NULL
were	NULL
of	NULL
phenotype	NULL
THP-1	NULL
,	NULL
PUS-1.8	NULL
and	NULL
P388D1	NULL
.	NULL

Some	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
promonocytic	NULL
cell	NULL
iine	NULL
U1	NULL
,	NULL
chronically	NULL
infected	NULL
with	NULL
HIV	NULL
,	NULL
which	NULL
expresses	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
HIV	NULL
transcription	NULL
when	NULL
un-stimulated	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
monocytes	NULL
were	NULL
prepared	NULL
from	NULL
human	NULL
blood	NULL
of	NULL
normal	NULL
volunteers	NULL
by	NULL
dextran	NULL
sedimentation	NULL
and	NULL
cen-trifugation	NULL
through	NULL
a	NULL
discontinuous	NULL
Ficoll-Hypaque	NULL
gradient	NULL
.	NULL

Monocytes	NULL
of	NULL
intermediate	NULL
homogeneity	NULL
(	NULL
80	NULL
%	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
one	NULL
cycle	NULL
of	NULL
adherence	NULL
onto	NULL
plastic	NULL
and	NULL
further	NULL
purification	NULL
(	NULL
95	NULL
%	NULL
)	NULL
was	NULL
achieved	NULL
by	NULL
repeated	NULL
cycles	NULL
of	NULL
washing	NULL
using	NULL
KPMI	NULL
mogium	NULL
over	NULL
a	NULL
period	NULL
to	NULL
remove	NULL
contaminating	NULL
non-adherent	NULL
cells	NULL
.	NULL

In	NULL
another	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
were	NULL
prepared	NULL
from	NULL
ascitic	NULL
fluid	NULL
induced	NULL
by	NULL
in-traperitoneal	NULL
injection	NULL
of	NULL
mineral	NULL
oil	NULL
or	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
and	NULL
purified	NULL
by	NULL
adherence	NULL
on	NULL
plastic	NULL
and	NULL
repeated	NULL
cycles	NULL
of	NULL
washing	NULL
.	NULL

Cell	NULL
transfection	NULL
Cells	NULL
were	NULL
transfected	NULL
either	NULL
in	NULL
suspension	NULL
or	NULL
adherent	NULL
using	NULL
the	NULL
conventional	NULL
DEAE-dextran	NULL
technique	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
10	NULL
uM	NULL
chloroquine	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
the	NULL
higher	NULL
concentrations	NULL
of	NULL
this	NULL
agent	NULL
originally	NULL
described	NULL
.	NULL

Cells	NULL
G.E	NULL
.	NULL

GRIFFIN	NULL
ET	NULL
AL	NULL
.	NULL

(	NULL
10	NULL
'	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV	NULL
enhancer	NULL
linked	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
.	NULL

Control	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
which	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
mutant	NULL
plasmid	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
altered	NULL
in	NULL
both	NULL
xB-binding	NULL
sites	NULL
using	NULL
DEAE-dextran	NULL
.	NULL

Then	NULL
,	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
RPMI	NULL
and	NULL
incubated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
nM	NULL
12-O-tetrade-canoyl-phorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
or	NULL
the	NULL
water-soluble	NULL
phorbol-12	NULL
,	NULL
13-dibutyrate	NULL
(	NULL
PDB	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
nM	NULL
which	NULL
is	NULL
more	NULL
easily	NULL
removed	NULL
from	NULL
cells	NULL
by	NULL
cycles	NULL
of	NULL
washing	NULL
.	NULL

Twenty	NULL
hours	NULL
after	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
cytoplasmic	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
(	NULL
Osborn	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
in	NULL
the	NULL
extracts	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Biorad	NULL
)	NULL
.	NULL

Chemical	NULL
assays	NULL
CAT	NULL
was	NULL
assayed	NULL
by	NULL
standard	NULL
methods	NULL
(	NULL
Nahel	NULL
and	NULL
RBaltimare	NULL
,	NULL
1987	NULL
)	NULL
on	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

NF-xB-binding	NULL
activity	NULL
was	NULL
determined	NULL
on	NULL
nuclear	NULL
extracts	NULL
containing	NULL
10	NULL
ug	NULL
protein	NULL
using	NULL
conventional	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
Leung	NULL
and	NULL
Nabel	NULL
,	NULL
1988	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pg	NULL
dIdC	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
xB	NULL
probe	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
competitor	NULL
containing	NULL
the	NULL
xB	NULL
site	NULL
or	NULL
an	NULL
unrelated	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
promoter	NULL
fragment	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
binding	NULL
.	NULL

RESULTS	NULL
Nuclear	NULL
NF-xB-binding	NULL
activity	NULL
NF-xB-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
figure	NULL
1	NULL
.	NULL

No	NULL
NF-xB-binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
promonocytic	NULL
cell	NULL
lines	NULL
in	NULL
the	NULL
unstimulated	NULL
state	NULL
(	NULL
fig	NULL
.	NULL

1A	NULL
;	NULL
HL-60	NULL
and	NULL
U937	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
stimulation	NULL
with	NULL
TPA	NULL
resulted	NULL
in	NULL
phenotypic	NULL
differentiation	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
NF-xB-binding	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
constitutive	NULL
NF-xB-binding	NULL
activity	NULL
was	NULL
demonstrated	NULL
in	NULL
the	NULL
mature	NULL
cell	NULL
lines	NULL
(	NULL
fig	NULL
.	NULL

1A	NULL
;	NULL
THP-1	NULL
,	NULL
PUS-1.8	NULL
and	NULL
P388DI	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-xB-binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
unstimulated	NULL
state	NULL
.	NULL

Since	NULL
the	NULL
immature	NULL
cell	NULL
lines	NULL
were	NULL
both	NULL
of	NULL
human	NULL
.	NULL

origin	NULL
and	NULL
the	NULL
mature	NULL
cell	NULL
lines	NULL
were	NULL
derived	NULL
from	NULL
mouse	NULL
cells	NULL
,	NULL
we	NULL
therefore	NULL
wished	NULL
to	NULL
demonstrate	NULL
NF-xB-binding	NULL
activity	NULL
in	NULL
cells	NULL
harvested	NULL
direcly	NULL
in	NULL
vivo	NULL
.	NULL

NF-xB-binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
in	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

TPA	NULL
stimulation	NULL
of	NULL
cells	NULL
is	NULL
known	NULL
to	NULL
be	NULL
irreversible	NULL
but	NULL
TPA	NULL
is	NULL
lipid	NULL
soluble	NULL
and	NULL
can	NULL
not	NULL
be	NULL
removed	NULL
from	NULL
cells	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
PDB	NULL
,	NULL
a	NULL
water-soluble	NULL
phor-bol	NULL
!	NULL

ester	NULL
which	NULL
can	NULL
easily	NULL
be	NULL
removed	NULL
from	NULL
celis	NULL
by	NULL
washing	NULL
,	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
see	NULL
if	NULL
short	NULL
storm	NULL
stimulation	NULL
(	NULL
2	NULL
h	NULL
)	NULL
followed	NULL
by	NULL
washing	NULL
resulted	NULL
in	NULL
long-term	NULL
expression	NULL
of	NULL
NF-xB-binding	NULL
activity	NULL
.	NULL

PDB	NULL
treatment	NULL
of	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
resulted	NULL
in	NULL
expression	NULL
of	NULL
NF-xB	NULL
after	NULL
2	NULL
h	NULL
of	NULL
treatment	NULL
which	NULL
was	NULL
still	NULL
present	NULL
48	NULL
h	NULL
after	NULL
the	NULL
phorbol	NULL
ester	NULL
was	NULL
washed	NULL
away	NULL
from	NULL
cells	NULL
.	NULL

HIV	NULL
transcription	NULL
HIV	NULL
CAT	NULL
Transcription	NULL
of	NULL
transfected	NULL
HIV-CAT	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
immature	NULL
monocytes	NULL
,	NULL
however	NULL
on	NULL
stimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
transcription	NULL
was	NULL
enhanced	NULL
17-fold	NULL
(	NULL
fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mature	NULL
cell	NULL
lines	NULL
constitutively	NULL
expressed	NULL
CAT	NULL
=	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
.	NULL

NF-xB	NULL
=	NULL
GM-CSF	NULL
=	NULL
granulocyte-macrophage/colany-stimulating	NULL
factor	NULL
.	NULL

PDB	NULL
=	NULL
IL	NULL
=	NULL
interleukin	NULL
.	NULL

TNF	NULL
=	NULL
LPS	NULL
=	NULL
lipopolysaccharide	NULL
.	NULL

|	NULL
TPA	NULL
_	NULL
=	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

phorbol-12,13-dibutyrate	NULL
.	NULL

tumour	NULL
necrosis	NULL
factor	NULL
.	NULL

12-O-tetradecanoyl-phorbol-1	NULL
3-acetate	NULL
.	NULL

HIV	NULL
TRANSCRIPTION	NULL
AND	NULL
NF-yxB	NULL
IN	NULL
MONOCYTE	NULL
CAT	NULL
and	NULL
such	NULL
expression	NULL
was	NULL
not	NULL
enhanced	NULL
by	NULL
phorbol	NULL
ester	NULL
stimulation	NULL
.	NULL

No	NULL
CAT	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
containing	NULL
mutant	NULL
xB	NULL
.	NULL

HIV	NULL
production	NULL
To	NULL
determine	NULL
whether	NULL
monocyte	NULL
differentiation	NULL
and	NULL
NF-xB	NULL
induction	NULL
affected	NULL
production	NULL
of	NULL
intact	NULL
virus	NULL
,	NULL
the	NULL
latently	NULL
infected	NULL
U1-cell	NULL
line	NULL
(	NULL
Folks	NULL
,	NULL
1988	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
PDE	NULL
or	NULL
TNF	NULL
«	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
phenotypic	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
occurred	NULL
as	NULL
monitored	NULL
using	NULL
change	NULL
in	NULL
cell	NULL
surface	NULL
characteristics	NULL
(	NULL
adhesion	NULL
,	NULL
Mol	NULL
expression	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HIV	NULL
production	NULL
was	NULL
enhanced	NULL
in	NULL
these	NULL
cells	NULL
as	NULL
shown	NULL
by	NULL
increased	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
and	NULL
p24	NULL
detected	NULL
in	NULL
the	NULL
incubating	NULL
medium	NULL
(	NULL
fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Both	NULL
NF-xB	NULL
activity	NULL
and	NULL
HIV	NULL
production	NULL
persisted	NULL
24-48	NULL
h	NULL
after	NULL
the	NULL
stimulus	NULL
was	NULL
removed	NULL
.	NULL

DISCUSSION	NULL
In	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-xB-binding	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
immature	NULL
cells	NULL
of	NULL
monocyte	NULL
lineage	NULL
,	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
cytokine	NULL
.	NULL

Such	NULL
cells	NULL
assumed	NULL
and	NULL
retained	NULL
a	NULL
macrophage	NULL
phenotype	NULL
as	NULL
a	NULL
result	NULL
of	NULL
such	NULL
stimulation	NULL
.	NULL

Transient	NULL
exposure	NULL
to	NULL
PDB	NULL
(	NULL
<	NULL
2	NULL
h	NULL
)	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
constitute	NULL
expression	NULL
of	NULL
NF-xB	NULL
binding	NULL
and	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
cell	NULL
morphology	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Once	NULL
monocyte	NULL
differentiation	NULL
occurred	NULL
,	NULL
however	NULL
,	NULL
NF-xB-binding	NULL
activity	NULL
remained	NULL
,	NULL
as	NULL
seen	NULL
constitutively	NULL
expressed	NULL
in	NULL
normal	NULL
monocytes	NULL
prepared	NULL
from	NULL
human	NULL
blood	NULL
and	NULL
mouse	NULL
peritoneal	NULL
exudate	NULL
(	NULL
fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
process	NULL
of	NULL
cell	NULL
differentiation	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
appearance	NULL
of	NULL
NF-xB	NULL
contributes	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
HIV	NULL
in	NULL
monocytes	NULL
.	NULL

This	NULL
has	NULL
great	NULL
clinical	NULL
implications	NULL
in	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
opportunistic	NULL
infection	NULL
,	NULL
or	NULL
HIV	NULL
infection	NULL
of	NULL
monocyte/macrophages	NULL
per	NULL
se	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
activate	NULL
HIV	NULL
transcription	NULL
and	NULL
therefore	NULL
presumably	NULL
enhance	NULL
disease	NULL
progression	NULL
.	NULL

It	NULL
is	NULL
known	NULL
,	NULL
however	NULL
,	NULL
that	NULL
NF-xB	NULL
is	NULL
not	NULL
the	NULL
sole	NULL
activa-tor	NULL
of	NULL
HIV	NULL
in	NULL
macrophages	NULL
.	NULL

For	NULL
example	NULL
GM-CSF	NULL
,	NULL
which	NULL
does	NULL
not	NULL
induce	NULL
NF-xB	NULL
binding	NULL
,	NULL
activates	NULL
HIV	NULL
expression	NULL
in	NULL
mature	NULL
macrophages	NULL
(	NULL
Koyanagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
which	NULL
already	NULL
contain	NULL
NF-xB	NULL
,	NULL
and	NULL
therefore	NULL
alternate	NULL
non-NF-xB	NULL
activation	NULL
mechanisms	NULL
are	NULL
likely	NULL
to	NULL
exist	NULL
in	NULL
vivo	NULL
.	NULL

Phorbol	NULL
esters	NULL
provide	NULL
a	NULL
potent	NULL
reproducible	NULL
stimulus	NULL
in	NULL
vitro	NULL
for	NULL
monocyte	NULL
differentiation	NULL
and	NULL
HIV	NULL
102	NULL
3	NULL
4	NULL
@	NULL
©	NULL
u-d	NULL
,	NULL
235	NULL
activation	NULL
;	NULL
however	NULL
,	NULL
such	NULL
a	NULL
stimulus	NULL
is	NULL
artificiel	NULL
.	NULL

It	NULL
is	NULL
now	NULL
becoming	NULL
apparent	NULL
that	NULL
,	NULL
in	NULL
clinical	NULL
HIV	NULL
infection	NULL
,	NULL
the	NULL
physiological	NULL
stimuli	NULL
most	NULL
likely	NULL
to	NULL
induce	NULL
HIV	NULL
activation	NULL
are	NULL
the	NULL
cytokines	NULL
or	NULL
some	NULL
bacterial	NULL
products	NULL
,	NULL
for	NULL
example	NULL
endotoxin	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
monocyte/macrophages	NULL
is	NULL
clearly	NULL
an	NULL
important	NULL
cell-activating	NULL
event	NULL
per	NULL
se	NULL
and	NULL
several	NULL
groups	NULL
have	NULL
reported	NULL
stimulation	NULL
of	NULL
cytokine	NULL
transcription	NULL
and	NULL
release	NULL
in	NULL
response	NULL
to	NULL
this	NULL
event	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
production	NULL
of	NULL
TNFa	NULL
,	NULL
B	NULL
and	NULL
interferon	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
inonocytes	NULL
(	NULL
Vyakarnam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
addi-	NULL
ugs	NULL
?	NULL

THP-1	NULL
PUS-1.8	NULL
+	NULL
0+	NULL
+	NULL
609+	NULL
f	NULL
a	NULL
a	NULL
>	NULL
-	NULL
*	NULL
«	NULL
8	NULL
£2	NULL
-	NULL
kB	NULL
kB	NULL
L2	NULL
LZ	NULL
-	NULL
kB	NULL
£8	NULL
A2	NULL
Le	NULL
10	NULL
-	NULL
10	NULL
s	NULL
10	NULL
50	NULL
10	NULL
5	NULL
®	NULL
S	NULL
%	NULL
®	NULL
t	NULL
be	NULL
'	NULL
n	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
-	NULL
x8	NULL
R2	NULL
-	NULL
10	NULL
10	NULL
kB	NULL
M2	NULL
-	NULL
10	NULL
10	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

NF-xB-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
immature	NULL
monocyte	NULL
_cell	NULL
lines	NULL
is	NULL
induced	NULL
by	NULL
exposure	NULL
to	NULL
40	NULL
nM	NULL
TPA	NULL
(	NULL
lanes	NULL
1-8	NULL
)	NULL
and	NULL
is	NULL
found	NULL
constitutive	NULL
ly	NULL
in	NULL
mature	NULL
macrophage	NULL
cell	NULL
lines	NULL
(	NULL
lanes	NULL
9-21	NULL
)	NULL
.	NULL

Arrows	NULL
denote	NULL
specific	NULL
inducible	NULL
complexes	NULL
completed	NULL
by	NULL
double-stranded	NULL
xB	NULL
oligonucleotide	NULL
.	NULL

Fig	NULL
.	NULL

1B	NULL
.	NULL

NF-xB-binding	NULL
activity	NULL
is	NULL
demonstrated	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mono	NULL
cytes	NULL
(	NULL
lanes	NULL
22-27	NULL
)	NULL
and	NULL
elicited	NULL
mouse	NULL
periton-al	NULL
macrophages	NULL
(	NULL
lanes	NULL
28-33	NULL
)	NULL
.	NULL

-	NULL
&	NULL
19	NULL
20	NULL
21	NULL
236	NULL
tion	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
THP-1	NULL
cells	NULL
acutely	NULL
infected	NULL
with	NULL
AIV	NULL
demonstrate	NULL
phenotypic	NULL
changes	NULL
associated	NULL
with	NULL
maturation	NULL
,	NULL
and	NULL
released	NULL
significantly	NULL
higher	NULL
levels	NULL
of	NULL
TNFa	NULL
and	NULL
IL-1B	NULL
compared	NULL
to	NULL
chronically	NULL
infected	NULL
cells	NULL
(	NULL
Molina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
same	NULL
group	NULL
reported	NULL
that	NULL
in	NULL
vitro	NULL
HIV	NULL
infection	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocyte/macrophages	NULL
did	NULL
not	NULL
result	NULL
in	NULL
cytokine	NULL
production	NULL
but	NULL
that	NULL
these	NULL
cells	NULL
retained	NULL
the	NULL
capac-	NULL
G.E	NULL
.	NULL

GRIFFIN	NULL
ET	NULL
AL	NULL
.	NULL

ity	NULL
to	NULL
produce	NULL
cytokines	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Molina	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
supported	NULL
by	NULL
a	NULL
similar	NULL
study	NULL
using	NULL
human	NULL
monocyte/macrophages	NULL
infected	NULL
in	NULL
vitro	NULL
(	NULL
Munis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

LPS	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
stimulus	NULL
of	NULL
HIV1	NULL
expression	NULL
in	NULL
monocyte/macrophage	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
surprisingly	NULL
LPS	NULL
has	NULL
no	NULL
similar	NULL
activity	NULL
towards	NULL
on	NULL
lym-phocytes	NULL
(	NULL
Pomerantz	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Some	NULL
evidence	NULL
is	NULL
also	NULL
accumulating	NULL
that	NULL
TNFa	NULL
released	NULL
from	NULL
A	NULL
HL-60	NULL
ugasr	NULL
a	NULL
Mutant	NULL
ln	NULL
Mutant	NULL
Plasmi¢	NULL
_	NULL
yiv.cat	NULL
_	NULL
KB	NULL
Plasmid	NULL
|	NULL
yiy-cat	NULL
_	NULL
KB	NULL
)	NULL
I	NULL
I	NULL
[	NULL
~I	NULL
25	NULL
25	NULL
CoNvERsiON	NULL
conversion	NULL
(	NULL
%	NULL
)	NULL
(	NULL
%	NULL
)	NULL
UAL	NULL
e	NULL
FOLD	NULL
STIMULATION	NULL
:	NULL
17.5	NULL
C	NULL
17.5	NULL
13	NULL
ACTIVATION	NULL
:	NULL
-	NULL
4	NULL
&	NULL
0	NULL
-	NULL
4	NULL
ook	NULL
~	NULL
3	NULL
B	NULL
ThP-1	NULL
P3B8D1	NULL
PUS-1.8	NULL
ick	NULL
Mutant	NULL
Mutant	NULL
Mutant	NULL
Plasmid	NULL
|-	NULL
yy-cat	NULL
_	NULL
KB	NULL
HIV-CAT	NULL
_	NULL
FB	NULL
HIV-CAT	NULL
__	NULL
KB	NULL
[	NULL
OA	NULL
C94	NULL
[	NULL
OAI	NULL
[	NULL
OCI	NULL
]	NULL
25	NULL
|	NULL
1.0	NULL
|	NULL
2.0	NULL
}	NULL
conversion	NULL
|	NULL
F	NULL
(	NULL
%	NULL
)	NULL
[	NULL
wa	NULL
]	NULL
CT	NULL
_C	NULL
]	NULL
FOLD	NULL
STIMULATION	NULL
:	NULL
0.67	NULL
ND	NULL
0.83	NULL
ND	NULL
1.0	NULL
ND	NULL
ACTIVATION	NULL
:	NULL
|	NULL
L	NULL
&	NULL
_	NULL
+	NULL
_	NULL
Lo	NULL
L	NULL
Fig	NULL
:	NULL
2	NULL
.	NULL

Activation	NULL
of	NULL
HIV-CAT	NULL
expression	NULL
in	NULL
immature	NULL
monocyte	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
is	NULL
elicited	NULL
by	NULL
exposure	NULL
to	NULL
40	NULL
nM	NULL
'_I	NULL
‘	NULL
PA	NULL
.	NULL

In	NULL
contrast	NULL
constitutive	NULL
CAT	NULL
activity	NULL
is	NULL
seen	NULL
in	NULL
unstimulated	NULL
mature	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

monocyte/macrophages	NULL
may	NULL
be	NULL
acting	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
HIV-infected	NULL
cells	NULL
to	NULL
promote	NULL
HIV	NULL
activation	NULL
(	NULL
Poli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Macrophages	NULL
are	NULL
known	NULL
to	NULL
be	NULL
crucial	NULL
cells	NULL
in	NULL
host	NULL
defence	NULL
against	NULL
infection	NULL
.	NULL

Many	NULL
stimuli	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
such	NULL
cells	NULL
via	NULL
different	NULL
mechanisms	NULL
and	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
a	NULL
final	NULL
common	NULL
end	NULL
point	NULL
of	NULL
terminal	NULL
differentiation	NULL
of	NULL
monocyte	NULL
into	NULL
macrophage	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-xB	NULL
,	NULL
.	NULL

Ws	NULL
have	NULL
demonstrated	NULL
that	NULL
such	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
HIV	NULL
transcription	NULL
and	NULL
virus	NULL
production	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
relationship	NULL
of	NULL
other	NULL
receptor-mediated	NULL
activation	NULL
processes	NULL
of	NULL
macrophages	NULL
,	NULL
for	NULL
example	NULL
phagocytosis	NULL
,	NULL
which	NULL
are	NULL
relevant	NULL
to	NULL
the	NULL
in	NULL
vivo	NULL
situation	NULL
clearly	NULL
deserve	NULL
investigation	NULL
.	NULL

Acknowledgements	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Well-come	NULL
Trust	NULL
(	NULL
G.E	NULL
.	NULL

Griffin	NULL
)	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
{	NULL
G.J	NULL
.	NULL

Mabel	NULL
and	NULL
5.	NULL
hunk®	NULL
)	NULL
.	NULL

Digures	NULL
are	NULL
seprinted	NULL
by	NULL
perinis-sion	NULL
from	NULL
Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
339	NULL
,	NULL
70-73	NULL
.	NULL

Copyright	NULL
(	NULL
C	NULL
)	NULL
1989	NULL
,	NULL
Macmillan	NULL
Magazines	NULL
Limited	NULL
.	NULL

L'induction	NULL
de	NULL
NF-xB	NULL
au	NULL
cours	NULL
de	NULL
la	NULL
différenciation	NULL
des	NULL
monocytes	NULL
est	NULL
associée	NULL
a	NULL
Pactivation	NULL
de	NULL
P'expression	NULL
des	NULL
genes	NULL
du	NULL
VIH	NULL
Les	NULL
cellules	NULL
de	NULL
la	NULL
lignée	NULL
monocyte-macrophage	NULL
sont	NULL
des	NULL
cibles	NULL
importantes	NULL
du	NULL
VIH	NULL
(	NULL
virus	NULL
de	NULL
l'immunodéfience	NULL
humaine	NULL
)	NULL
.	NULL

Nous	NULL
rapportons	NULL
ici	NULL
que	NULL
la	NULL
différenciation	NULL
phénotypique	NULL
de	NULL
lignées	NULL
de	NULL
cellules	NULL
monocytaires	NULL
induite	NULL
par	NULL
des	NULL
esters	NULL
de	NULL
phorbol	NULL
ou	NULL
par	NULL
le	NULL
TNFa	NULL
(	NULL
tumour	NULL
necrosis	NULL
factor	NULL
)	NULL
est	NULL
associée	NULL
a	NULL
Pexpression	NULL
du	NULL
facteur	NULL
nucléaire	NULL
kappa	NULL
B	NULL
(	NULL
NF-xB	NULL
)	NULL
.	NULL

Paral-lélement	NULL
a	NULL
une	NULL
telle	NULL
différenciation	NULL
,	NULL
la	NULL
transcription	NULL
du	NULL
VIH	NULL
,	NULL
controlée	NULL
par	NULL
la	NULL
construction	NULL
d'un	NULL
géne	NULL
reportant	NULL
le	NULL
LTR	NULL
(	NULL
long	NULL
terminal	NULL
HIV	NULL
TRANSCRIPTION	NULL
AND	NULL
NF-yxB	NULL
IN	NULL
MONOCYTE	NULL
Stimulant	NULL
:	NULL
_	NULL
-	NULL
_	NULL
PDB	NULL
PDB	NULL
PMA	NULL
Incubation	NULL
(	NULL
hrs	NULL
)	NULL
:	NULL
_	NULL
48	NULL
48	NULL
48	NULL
_	NULL
4	NULL
Post-	NULL
Treatment	NULL
incubation	NULL
(	NULL
hrs	NULL
)	NULL
:	NULL
24	NULL
24	NULL
24	NULL
0	NULL
Cell	NULL
:	NULL
2000	NULL
j	NULL
ACTIVITY	NULL
(	NULL
CPM	NULL
)	NULL
1000	NULL
DAYS	NULL
POST-TREATMENT	NULL
237	NULL
C	NULL
100	NULL
[	NULL
p24	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

DAYS	NULL
POST-TREATMENT	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Increased	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
A	NULL
)	NULL
and	NULL
HIV	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
in	NULL
an	NULL
HIV	NULL
chronically	NULL
infected	NULL
promonocytic	NULL
cell	NULL
line	NULL
,	NULL
U1	NULL
,	NULL
following	NULL
cellular	NULL
differentiation	NULL
induced	NULL
by	NULL
PDB	NULL
or	NULL
TPA	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
activity	NULL
and	NULL
p24-antigen	NULL
activity	NULL
were	NULL
determined	NULL
in	NULL
tissue	NULL
culture	NULL
supernatants	NULL
(	NULL
B	NULL
)	NULL
as	NULL
indices	NULL
of	NULL
HIV	NULL
production	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
&	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
2	NULL
nM	NULL
PDB	NULL
(	NULL
&	NULL
)	NULL
,	NULL
20	NULL
nM	NULL
PDB	NULL
(	NULL
@	NULL
)	NULL
or	NULL
10°	NULL
units/ml	NULL
TNFa	NULL
for	NULL
48	NULL
h	NULL
followed	NULL
by	NULL
washing	NULL
and	NULL
incubation	NULL
for	NULL
a	NULL
further	NULL
24	NULL
or	NULL
48	NULL
h.	NULL
du	NULL
VIH	NULL
,	NULL
set	NULL
activée	NULL
dans	NULL
de	NULL
telles	NULL
celluies	NULL
sous	NULL
i'infiluence	NULL
de	NULL
l	NULL
’	NULL
augmentation	NULL
de	NULL
l	NULL
’	NULL
expression	NULL
m	NULL
da	NULL
NF-	NULL
@	NULL
B	NULL
,	NULL
De	NULL
mam	NULL
»	NULL
,	NULL
aans	NULL
une	NULL
``	NULL
511W	NULL
cellulaire	NULL
promonocytaire	NULL
infectée	NULL
chroniquement	NULL
par	NULL
le	NULL
VIH	NULL
,	NULL
lexpression	NULL
du	NULL
NF-xB	NULL
et	NULL
la	NULL
transcription	NULL
du	NULL
VIH	NULL
sont	NULL
stimulées	NULL
par	NULL
les	NULL
esters	NULL
de	NULL
phorbol	NULL
ou	NULL
le	NULL
TNF	NULL
.	NULL

Ainsi	NULL
,	NULL
la	NULL
stimulation	NULL
de	NULL
lignées	NULL
de	NULL
cellules	NULL
monocytaires	NULL
par	NULL
les	NULL
esters	NULL
de	NULL
phorbol	NULL
ou	NULL
par	NULL
le	NULL
TNFa	NULL
induit	NULL
la	NULL
différenciation	NULL
cellulaire	NULL
et	NULL
active	NULL
la	NULL
transcription	NULL
du	NULL
VIH	NULL
.	NULL

Un	NULL
tel	NULL
processus	NULL
peut	NULL
avoir	NULL
des	NULL
implications	NULL
fondamentales	NULL
dans	NULL
la	NULL
pathogenése	NULL
du	NULL
VIH	NULL
in	NULL
vitro	NULL
,	NULL
et	NULL
peut	NULL
étre	NULL
important	NULL
dans	NULL
la	NULL
progression	NULL
de	NULL
la	NULL
maladie	NULL
induite	NULL
par	NULL
des	NULL
infections	NULL
opportunistes	NULL
impli-quant	NULL
directement	NULL
ou	NULL
indirecte-ment	NULL
les	NULL
macrophages	NULL
.	NULL

Mots-clés	NULL
:	NULL
VIH	NULL
,	NULL
Monocyte	NULL
,	NULL
Macrophage	NULL
,	NULL
SIDA	NULL
,	NULL
Facteur	NULL
nucléaire	NULL
kappa	NULL
B	NULL
;	NULL
Esters	NULL
de	NULL
phor-bol	NULL
,	NULL
TNF	NULL
«	NULL
,	NULL
Maturation	NULL
cellulaire	NULL
,	NULL
Transcription	NULL
.	NULL

Reference	NULL
:	NULL
Donahue	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Johnson	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Zon	NULL
,	NULL
L.1	NULL
.	NULL

,	NULL
Clark	NULL
,	NULL
S.C.	NULL
&	NULL
Groopman	NULL
.	NULL

J.E	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
,	NULL
Suppression	NULL
of	NULL
in	NULL
vitro	NULL
kaematopoiesis	NULL
following	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
326	NULL
,	NULL
200-203	NULL
.	NULL

Folks	NULL
,	NULL
T.M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
,	NULL
Infection	NULL
and	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
purified	NULL
progenitor	NULL
cells	NULL
of	NULL
normal	NULL
human	NULL
bone	NULL
marrow	NULL
.	NULL

Science	NULL
,	NULL
242	NULL
,	NULL
919-922	NULL
.	NULL

Folks	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
Justernent	NULL
,	NULL
J.	NULL
,	NULL
Kinter	NULL
,	NULL
A.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

&	NULL
Fauci	NULL
,	NULL
A.S.	NULL
(	NULL
1988	NULL
)	NULL
,	NULL
Cytokine-induced	NULL
expression	NULL
of	NULL
HIV-1	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
pneumonocyte	NULL
cell	NULL
line	NULL
.	NULL

Science	NULL
,	NULL
238	NULL
,	NULL
800-802	NULL
.	NULL

Griffin	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-xB	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
339	NULL
,	NULL
70-73	NULL
.	NULL

Ho	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Rota	NULL
,	NULL
T.R	NULL
.	NULL

&	NULL
Hirsch	NULL
,	NULL
M.S	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
,	NULL
Infection	NULL
of	NULL
monocyte/	NULL
macrophage	NULL
by	NULL
human	NULL
T	NULL
lym-photropic	NULL
virus	NULL
type	NULL
III	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
77	NULL
,	NULL
1712-1715	NULL
.	NULL

Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
O'Brien	NULL
,	NULL
W.A	NULL
.	NULL

,	NULL
Zhao	NULL
,	NULL
J.Q	NULL
.	NULL

,	NULL
Golde	NULL
,	NULL
PW	NULL
.	NULL

,	NULL
Glasson	NULL
,	NULL
J.C.	NULL
&	NULL
Chen	NULL
,	NULL
I.S.Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
,	NULL
Cytokines	NULL
alter	NULL
production	NULL
of	NULL
HIV-1	NULL
from	NULL
primary	NULL
mononuclear	NULL
phagacy-tes	NULL
.	NULL

Scrence	NULL
241	NULL
,	NULL
1673-	NULL
1675	NULL
Leung	NULL
Kwanyee	NULL
&	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
,	NULL
HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-xB-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

Meltzer	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Skillman	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
Hoo-ver	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Hanson	NULL
,	NULL
B.D	NULL
.	NULL

,	NULL
Tur-pin	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Kalter	NULL
,	NULL
C.	NULL
&	NULL
Gendelman	NULL
,	NULL
H.E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
,	NULL
Macrophages	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
11	NULL
,	NULL
217-223	NULL
.	NULL

Molina	NULL
,	NULL
J.-M.	NULL
,	NULL
Scadden	NULL
,	NULL
D.T	NULL
.	NULL

,	NULL
Byrn	NULL
,	NULL
R.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

&	NULL
Groopman	NULL
,	NULL
J.E	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
Production	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1B	NULL
by	NULL
monocytic	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
84	NULL
,	NULL
``	NULL
733-737	NULL
.	NULL

Molina	NULL
,	NULL
J.-M.	NULL
,	NULL
Schindler	NULL
,	NULL
R.	NULL
,	NULL
Ferriani	NULL
,	NULL
R.	NULL
,	NULL
Sakaguchi	NULL
,	NULL
M.	NULL
,	NULL
Vannier	NULL
,	NULL
E.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

&	NULL
Groopman	NULL
,	NULL
J.E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
,	NULL
Production	NULL
of	NULL
cytokines	NULL
by	NULL
peripheral	NULL
blood	NULL
monocyte/macrophages	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
.	NULL

J.	NULL
infect	NULL
.	NULL

Dis	NULL
.	NULL

,	NULL
161	NULL
,	NULL
888-893	NULL
.	NULL

Munis	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Richman	NULL
,	NULL
D.D	NULL
.	NULL

&	NULL
Korn-	NULL
bluth	NULL
,	NULL
R.S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
,	NULL
Human	NULL
immunodeficiency	NULL
virus-1	NULL
infection	NULL
of	NULL
macrophages	NULL
in	NULL
vitro	NULL
neither	NULL
induces	NULL
tumour	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
/cachectin	NULL
gene	NULL
expression	NULL
nor	NULL
alters	NULL
TNF/ca-chectin	NULL
induction	NULL
by	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
85	NULL
,	NULL
591-596	NULL
.	NULL

Nabel	NULL
,	NULL
G.J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
,	NULL
An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
G.E	NULL
.	NULL

GRIFFIN	NULL
ET	NULL
AL	NULL
.	NULL

cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

Proc	NULL
.	NULL

nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

(	NULL
Wash.	NULL
)	NULL
,	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
Kinter	NULL
,	NULL
A.	NULL
,	NULL
Justement	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Kehrl	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
Bressler	NULL
,	NULL
P.	NULL
,	NULL
Stan-ley	NULL
,	NULL
S.	NULL
&	NULL
Fauci	NULL
,	NULL
A.S.	NULL
(	NULL
1990	NULL
)	NULL
,	NULL
Tumour	NULL
necrosis	NULL
factor	NULL
«	NULL
function	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

(	NULL
Wash.	NULL
)	NULL
,	NULL
87	NULL
,	NULL
782-785	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.J.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Trono	NULL
,	NULL
D.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
,	NULL
Lipopolysaccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulator	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
.	NULL

J.	NULL
exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
172	NULL
,	NULL
253-261	NULL
.	NULL

Vyakarnam	NULL
,	NULL
A.	NULL
,	NULL
McKeating	NULL
,	NULL
J.	NULL
,	NULL
Mea-	NULL
ger	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Beverley	NULL
,	NULL
P.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
,	NULL
Tumour	NULL
necrosis	NULL
factors	NULL
(	NULL
«	NULL
and	NULL
)	NULL
induced	NULL
by	NULL
HIV-1	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
potentiate	NULL
virus	NULL
replication	NULL
.	NULL

AIDS	NULL
,	NULL
4	NULL
,	NULL
21-27	NULL
.	NULL

